SCHEMBL5174394

SCHEMBL5174394

CC(C=O)Cc1ccc(Br)s1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
KDM4E B2RXH2 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
ALDH1A1 P00352 4/20 0.34
GSK3B P49841 2/20 0.32
HPGD P15428 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
PARP1 P09874 1/20 0.31
DAO P14920 1/20 0.31
TNFRSF1A P19438 1/20 0.30
KMT2A Q03164 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13767970 0.79 TP53 (0.44) TP53TSHRL3MBTL1ALDH1A1HPGD
SCHEMBL10130574 0.78 KDM4E (0.43) KDM4ETDP1L3MBTL1CES2CES1
SCHEMBL13767971 0.78 TP53 (0.43) TP53TSHRALDH1A1HPGD
SCHEMBL5972869 0.78 CES2 (0.35) KDM4ETDP1L3MBTL1CES2CES1
SCHEMBL24311836 0.78 CES2 (0.35) KDM4ETDP1L3MBTL1CES2CES1
SCHEMBL24312307 0.77 KDM4E (0.35) KDM4ETDP1L3MBTL1CES2CES1
SCHEMBL5147000 0.75 KDM4E (0.41) TSHRKDM4ETDP1L3MBTL1CES2
SCHEMBL10387818 0.75 KDM4E (0.41) KDM4ETDP1ALDH1A1
SCHEMBL11200328 0.75 TP53 (0.61) TP53TSHRKMT2A
SCHEMBL6641492 0.75 KDM4E (0.41) KDM4ETDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784400-A1 HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-05-16 EP disclosed
WO-2006023462-A1 HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2006-03-02 WO disclosed